- Global Pharma News & Resources

Terminal Sterilization Services Market is projected to reach US$ 33.5 billion by 2032, at a CAGR of 12.7%

According to a Future Market Insights report, the Global Terminal Sterilisation Services Market size is expected to reach US$ 33.5 billion by the end of 2032, growing at a compound annual growth rate (CAGR) of 12.7% from 2022 to 2032.

A high prevalence of chronic illnesses, an increase in the frequency of Healthcare Acquired Infections (HAIs), and the impact of the COVID-19 pandemic are all driving market expansion. COVID-19 has increased demand for sterilising materials including heat sterilisers and ethylene oxide. As there is a significant requirement for effective sanitization of equipment and surroundings, the use of sterilisation equipment and services has increased in hospitals, clinics, diagnostic labs, pharmaceutical manufacturing units, and the biopharmaceutical industry.

Request a sample copy of this research report@

Increased awareness of diseases and infections caused by non-sterile environments, as well as considerable increases in funding for hospital infrastructure, research, and public health adaption to terminal sterility, have all contributed to the market’s recent pace.

Companies can create a sterilisation programme by following the voluntary consensus standards developed by the Association for the Advancement of Medical Instrumentation (AAMI) and ISO criteria, without the need for a big and time-consuming Sterilisation technology department. These standards are also used by regulatory authorities such as the FDA to determine product sterility.

Key Takeaways:

  • By the end of 2032, the United States is expected to have the largest market, worth $9.5 billion.
  • The market in the United Kingdom is expected to generate an absolute dollar potential of US$ 1.4 billion between 2022 and 2032.
  • Japan’s market is estimated to reach US$ 1.7 billion by 2032.
  • The Ethylene Oxide market is estimated to grow at the quickest CAGR of more than 14% between 2022 and 2032.

Get a Discount on Report@

North America to remain the largest market for Terminal Sterilization Services

North America is predicted to account for the largest share of the global terminal sterilization services market during the forecast period. A huge client base, greater usage of enhanced sterilization technologies, and highly modern health-care infrastructure are projected to propel the market in North America in the next years.

Competitive Landscape

Some of the key players in the terminal sterilization services market include Johnson And Johnson, DuPont, Steris Plc, Getinge Group, Cantel Medical, Matachana Group, Sterigenics International LLC, and Olympus Corp.

The following are some of the most recent developments from key terminal sterilization service providers:

  • Amcor announced the development of a novel healthcare lidding technology in August 2021, which would be used for combination items containing two or more regulated components.
  • Johnson & Johnson stated in April 2019 that it has completed the sale of its Advanced Sterilization Products (ASP) business, a part of Ethicon, Inc., to Fortive Corporation for an estimated US$ 2.8 billion.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@

Market Segments Covered in Terminal Sterilization Services Market Analysis

By Type:

  • Ethylene Oxide
  • Irradiation
  • Moist Heat Terminal sterilization
  • Other Types

By End Uses:

  • Hospitals & Clinics
  • Pharma
  • Other End-uses

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.


Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
Browse All Reports:

Editor Details

Last Updated: 03-May-2023